417 related articles for article (PubMed ID: 28250576)
1. Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.
Madeira MH; Boia R; Ambrósio AF; Santiago AR
Mediators Inflamm; 2017; 2017():4761081. PubMed ID: 28250576
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases.
Boia R; Ambrósio AF; Santiago AR
Ophthalmic Res; 2016; 55(4):212-8. PubMed ID: 26959995
[TBL] [Abstract][Full Text] [Related]
3. Treatment with A
Boia R; Elvas F; Madeira MH; Aires ID; Rodrigues-Neves AC; Tralhão P; Szabó EC; Baqi Y; Müller CE; Tomé ÂR; Cunha RA; Ambrósio AF; Santiago AR
Cell Death Dis; 2017 Oct; 8(10):e3065. PubMed ID: 28981089
[TBL] [Abstract][Full Text] [Related]
4. Caffeine attenuates lipopolysaccharide-induced neuroinflammation.
Brothers HM; Marchalant Y; Wenk GL
Neurosci Lett; 2010 Aug; 480(2):97-100. PubMed ID: 20541589
[TBL] [Abstract][Full Text] [Related]
5. Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation?
Ruggiero M; Calvello R; Porro C; Messina G; Cianciulli A; Panaro MA
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361750
[TBL] [Abstract][Full Text] [Related]
6. Microglia Mediated Neuroinflammation: Focus on PI3K Modulation.
Cianciulli A; Porro C; Calvello R; Trotta T; Lofrumento DD; Panaro MA
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947676
[TBL] [Abstract][Full Text] [Related]
7. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
[TBL] [Abstract][Full Text] [Related]
8. Blockade of microglial adenosine A
Aires ID; Boia R; Rodrigues-Neves AC; Madeira MH; Marques C; Ambrósio AF; Santiago AR
Glia; 2019 May; 67(5):896-914. PubMed ID: 30667095
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A
Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
Mov Disord; 2022 Apr; 37(4):853-857. PubMed ID: 35001424
[TBL] [Abstract][Full Text] [Related]
10. Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.
Santiago AR; Baptista FI; Santos PF; Cristóvão G; Ambrósio AF; Cunha RA; Gomes CA
Mediators Inflamm; 2014; 2014():465694. PubMed ID: 25132733
[TBL] [Abstract][Full Text] [Related]
11. Adora2A downregulation promotes caffeine neuroprotective effect against LPS-induced neuroinflammation in the hippocampus.
Lemes Dos Santos Sanna P; Bernardes Carvalho L; Cristina Dos Santos Afonso C; de Carvalho K; Aires R; Souza J; Rodrigues Ferreira M; Birbrair A; Martha Bernardi M; Latini A; Foganholi da Silva RA
Brain Res; 2024 Jun; 1833():148866. PubMed ID: 38494098
[TBL] [Abstract][Full Text] [Related]
12. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling.
Meng F; Guo Z; Hu Y; Mai W; Zhang Z; Zhang B; Ge Q; Lou H; Guo F; Chen J; Duan S; Gao Z
Brain; 2019 Mar; 142(3):700-718. PubMed ID: 30689733
[TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation regulates microglial responses to tissue damage in vivo.
Gyoneva S; Davalos D; Biswas D; Swanger SA; Garnier-Amblard E; Loth F; Akassoglou K; Traynelis SF
Glia; 2014 Aug; 62(8):1345-60. PubMed ID: 24807189
[TBL] [Abstract][Full Text] [Related]
14. An outlook on the role of decaffeinated coffee in neurodegenerative diseases.
Colombo R; Papetti A
Crit Rev Food Sci Nutr; 2020; 60(5):760-779. PubMed ID: 30614247
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases.
Ramírez Hernández E; Sánchez-Maldonado C; Mayoral Chávez MA; Hernández-Zimbrón LF; Patricio Martínez A; Zenteno E; Limón Pérez de León ID
Expert Rev Neurother; 2020 May; 20(5):439-448. PubMed ID: 32303136
[No Abstract] [Full Text] [Related]
16. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A
Jacobson KA; Gao ZG; Matricon P; Eddy MT; Carlsson J
Br J Pharmacol; 2022 Jul; 179(14):3496-3511. PubMed ID: 32424811
[TBL] [Abstract][Full Text] [Related]
19. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
Rivera-Oliver M; Díaz-Ríos M
Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
[TBL] [Abstract][Full Text] [Related]
20. A
Merighi S; Borea PA; Varani K; Vincenzi F; Jacobson KA; Gessi S
Curr Med Chem; 2022; 29(24):4138-4151. PubMed ID: 34844537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
